Paper39337654
The Effects of Growth Hormone Treatment Beyond Growth Promotion in Patients with Genetic Syndromes: A Systematic Review of the Literature.
Kucharska A and 5 others. Int J Mol Sci, 2024. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Effects of Growth Hormone Treatment Beyond Growth Promotion in Patients with Genetic Syndromes: A Systematic Review of the Literature. Papers, record 39337654. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337654
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Effects of Growth Hormone Treatment Beyond Growth Promotion in Patients with Genetic Syndromes: A Systematic Review of the Literature.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Human Growth Hormone | Major topic |
| Prader-Willi Syndrome | Major topic |
| Humans | |
| Growth Disorders | |
| Noonan Syndrome | |
| Recombinant Proteins | |
| Turner Syndrome |
Source PubMed
References228
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,003,096 | Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. | J Clin Endocrinol Metab | 2006 | https://conductscience.org/library/papers/17003096 | PubMed |
| 2 | 36,979,809 | A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979809 | PubMed |
| 3 | 19,622,627 | Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial. | J Clin Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19622627 | PubMed |
| 4 | 27,927,458 | Spinal Deformity in Russell-Silver Syndrome. | Spine Deform | 2015 | https://conductscience.org/library/papers/27927458 | PubMed |
| 5 | 18,562,489 | Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11. | Eur J Endocrinol | 2008 | https://conductscience.org/library/papers/18562489 | PubMed |
| 6 | 21,280,141 | MLL2 mutation spectrum in 45 patients with Kabuki syndrome. | Hum Mutat | 2011 | https://conductscience.org/library/papers/21280141 | PubMed |
| 7 | 24,776,754 | Comparison of body surface area versus weight-based growth hormone dosing for girls with Turner syndrome. | Horm Res Paediatr | 2014 | https://conductscience.org/library/papers/24776754 | PubMed |
| 8 | 20,685,669 | Epigenotype-phenotype correlations in Silver-Russell syndrome. | J Med Genet | 2010 | https://conductscience.org/library/papers/20685669 | PubMed |
| 9 | 20,847,547 | Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. | Horm Res Paediatr | 2011 | https://conductscience.org/library/papers/20847547 | PubMed |
| 10 | 18,079,757 | Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. | Nat Rev Drug Discov | 2008 | https://conductscience.org/library/papers/18079757 | PubMed |
| 11 | 25,951,829 | A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome. | J Med Genet | 2015 | https://conductscience.org/library/papers/25951829 | PubMed |
| 12 | 37,555,570 | Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement. | Clin Endocrinol (Oxf) | 2024 | https://conductscience.org/library/papers/37555570 | PubMed |
| 13 | 17,192,298 | The effect of growth hormone on the response of total and acylated ghrelin to a standardized oral glucose load and insulin resistance in children with Prader-Willi syndrome. | J Clin Endocrinol Metab | 2007 | https://conductscience.org/library/papers/17192298 | PubMed |
| 14 | 29,298,282 | The effects of growth hormone therapy on the somatic development of a group of Polish children with Silver-Russell syndrome. | Neuro Endocrinol Lett | 2017 | https://conductscience.org/library/papers/29298282 | PubMed |
| 15 | 27,381,990 | Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study. | Nutr Metab Cardiovasc Dis | 2016 | https://conductscience.org/library/papers/27381990 | PubMed |
| 16 | 35,307,998 | Management of Prader-Labhart-Willi syndrome in children and in adults, with particular emphasis on the treatment with recombinant human growth hormone. | Pediatr Endocrinol Diabetes Metab | 2022 | https://conductscience.org/library/papers/35307998 | PubMed |
| 17 | 10,792,330 | A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial. | Clin Endocrinol (Oxf) | 2000 | https://conductscience.org/library/papers/10792330 | PubMed |
| 18 | 37,476,877 | Body proportions in patients with Turner syndrome on growth hormone treatment. | Turk J Med Sci | 2023 | https://conductscience.org/library/papers/37476877 | PubMed |
| 19 | 11,155,014 | Hepatic adenoma associated with recombinant human growth hormone therapy in a patient with Turner's syndrome. | Dig Surg | 2000 | https://conductscience.org/library/papers/11155014 | PubMed |
| 20 | 25,263,744 | Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome. | Acta Paediatr | 2015 | https://conductscience.org/library/papers/25263744 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,704,858 | Recombinant growth hormone therapy in a patient with brachydactyly: case report with literature review. | Pediatr Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/42704858 | PubMed |
| 42,457,321 | [Multiple clinical effects of recombinant human growth hormone therapy]. | Zhongguo Dang Dai Er Ke Za Zhi | 2026 | https://conductscience.org/library/papers/42457321 | PubMed |
| 41,597,499 | Changes in Bioelectrical Impedance Analysis and Lipid Profile in Children Diagnosed with Short Stature Who Undergo Growth Hormone Therapy: One Single-Center Experience. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41597499 | PubMed |
| 40,869,907 | Two Years of Growth Hormone Therapy in a Child with Severe Short Stature Due to Overlap Syndrome with a Novel SETD5 Gene Mutation: Case Report and Review of the Literature. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40869907 | PubMed |
| 40,386,356 | Two cases of autosomal dominant familial short stature associated with COL11A2 gene variant and the therapeutic response to recombinant human growth hormone. | Transl Pediatr | 2025 | https://conductscience.org/library/papers/40386356 | PubMed |
| 40,189,669 | The genetic basis of human height. | Nat Rev Genet | 2025 | https://conductscience.org/library/papers/40189669 | PubMed |
| 39,904,816 | Growth hormone signaling and clinical implications: from molecular to therapeutic perspectives. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39904816 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GH1 | 2,688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39337654
GET https://conductscience.org/api/papers/v1/39337654/references?page=2